Florim USA obtains WELL health safety rating

0




Clarksville, TN, May 6, 2022 – Florim USA announced that it has achieved WELL Health Safety Rating through the International WELL Building Institute (IWBI), and is the leading porcelain tile manufacturer and the largest manufacturer in the world to accomplish this goal, according to the company.

The WELL Health Safety Rating is an evidence-based, third-party verified rating for all types of new and existing buildings and spaces, focusing on operational policies, maintenance protocols, employee engagement stakeholders and contingency plans to deal with a post-Covid-19 environment now and into the future. WELL Health-Safety Rating can help users prepare their spaces for reintegration in the wake of the Covid-19 pandemic, instilling confidence in those walking through the building as well as the wider community.

The WELL Health-Safety Rating provides a centralized source and governing body to validate the efforts of owners and operators. It draws on insights from the IWBI task, the World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC), as well as recognized normative associations such as the American Society for Testing and Materials (ASTM) and ASHRAE. It sets the building standard and frame of reference for advancing health in buildings and spaces of all kinds.

To achieve the WELL Health-Safety rating, Florim USA has implemented a series of internal protocols and measures such as additional cleaning of surfaces, masking policies at least in accordance with local requirements, remote working policies and a staggered return to the office. Policies and procedures such as indoor air quality, employee benefits and natural disaster response rates were reviewed as part of obtaining the rating.

Florim USA has been awarded the WELL Health-Safety rating following successful completion of third-party documentation review by GBCI to confirm that it has met feature-specific intents and requirements.

Related Topics:United States






Share.

Comments are closed.